HNWAG
BIIB icon

High Net Worth Advisory Group’s Biogen BIIB Stock Holding History

High Net Worth Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15
Closed -$4.15K – 234
2022
Q4 		$4.15K Hold
15
– – ﹤0.01% 548
2022
Q3 		$4K Hold
15
– – ﹤0.01% 594
2022
Q2 		$3K Hold
15
– – ﹤0.01% 611
2022
Q1 		$3K Hold
15
– – ﹤0.01% 617
2021
Q4 		$4K Buy
+15
New +$3.86K ﹤0.01% 615

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

High Net Worth Advisory Group's BIIB Position: Q1 2023 in Review

High Net Worth Advisory Group sold out of Biogen (BIIB) in Q1 2023, closing a stake of 15 shares — an estimated $4.15K sold.

High Net Worth Advisory Group first reported a position in BIIB in Q4 2021 and held it in 5 quarters. The position peaked at $4.15K in Q4 2022. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • High Net Worth Advisory Group reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • High Net Worth Advisory Group sold 15 Biogen shares in Q1 2023, an estimated $4.15K.
  • High Net Worth Advisory Group first reported a position in Biogen in Q4 2021 and held it in 5 quarters.
  • High Net Worth Advisory Group's Biogen position peaked at $4.15K in Q4 2022.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on High Net Worth Advisory Group's 13F filing for Q1 2023, filed 20 Apr 2023.